| Sumario: | Palliative care has become a vital aspect of holistic, patient-centred management for individuals living with autoimmune diseases. In recent years, there has been a growing interest among patients and some healthcare professionals in complementary and integrative strategies, such as homoeopathy, to help manage symptoms, enhance quality of life (QoL), and provide supportive care alongside standard disease-modifying treatments. This paper examines the current body of evidence on the use of homoeopathy in supportive and palliative settings and addresses important safety and regulatory considerations. It also outlines a future clinical and research agenda to determine whether homoeopathy can be integrated responsibly into palliative care for autoimmune disorders. Overall, the evidence remains inconclusive: while some smaller and heterogeneous studies suggest patient-reported improvements, robust and adequately designed randomized trials are still necessary. Until such evidence is available, the emphasis should remain on patient safety, informed decision- making, and collaborative care within established palliative frameworks.
|
|---|